Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $98.94 million. The enterprise value is $93.61 million.

Market Cap	98.94M
Enterprise Value	93.61M

Important Dates

The last earnings date was Tuesday, March 31, 2026, after market close.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

TTRX has 29.45 million shares outstanding. The number of shares has increased by 3.24% in one year.

Current Share Class	29.45M
Shares Outstanding	29.45M
Shares Change (YoY)	+3.24%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	59.47%
Owned by Institutions (%)	1.64%
Float	10.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	20.92
P/TBV Ratio	26.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.02.

Current Ratio	0.87
Quick Ratio	0.85
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -141.67% and return on invested capital (ROIC) is -155.46%.

Return on Equity (ROE)	-141.67%
Return on Assets (ROA)	-51.53%
Return on Invested Capital (ROIC)	-155.46%
Return on Capital Employed (ROCE)	-95.13%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.62
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.31
Average Volume (20 Days)	21,808

Short Selling Information

The latest short interest is 66,046, so 0.22% of the outstanding shares have been sold short.

Short Interest	66,046
Short Previous Month	70,807
Short % of Shares Out	0.22%
Short % of Float	0.63%
Short Ratio (days to cover)	3.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.86M
Pretax Income	-3.19M
Net Income	-3.19M
EBITDA	-5.81M
EBIT	-5.86M
Earnings Per Share (EPS)	-$0.12

Balance Sheet

The company has $5.08 million in cash and $80,376 in debt, with a net cash position of $5.00 million or $0.17 per share.

Cash & Cash Equivalents	5.08M
Total Debt	80,376
Net Cash	5.00M
Net Cash Per Share	$0.17
Equity (Book Value)	4.69M
Book Value Per Share	0.16
Working Capital	-806,980

Cash Flow

Operating Cash Flow	-2.56M
Capital Expenditures	n/a
Depreciation & Amortization	52,746
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.24%
Shareholder Yield	-3.24%
Earnings Yield	-3.24%
FCF Yield	n/a

Analyst Forecast

The average price target for TTRX is $8.00, which is 138.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	138.10%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1